Mesoblast Limited (MSB)

Index:

ASX 200

 NULL
   
  • 52 Week High: NULL
  • 52 Week Low: $0.26
  • Currency: Australian Dollars
  • Shares Issued: 482.64m

MSB Overview

Mesoblast is an Australian biotechnology company seeking to develop treatments for orthopaedic conditions, including the commercialisation of a unique adult stem cell technology aimed at the regeneration and repair of bone and cartilage. The shares listed on the ASX in December 2004.

3 Month Chart

3 Month Chart

1 Year Chart

1 Year Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0%
Div Cover n/a
Op Mrgn -213.8%
ROCE 265.2%
Latest F'cast
P/E n/a
PEG n/a
Pr/Revenue 23.0
Pr/Book 1.3
Latest F'cast
Revenue 89.5%
PBT n/a
EPS n/a
DPS n/a

MSB Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-08 n/a (10.06) (8.72)¢ n/a n/a n/a n/a 0.0%
30-Jun-09 n/a (12.29) (9.79)¢ n/a n/a n/a n/a 0.0%
30-Jun-10 n/a (14.78) (10.40)¢ n/a n/a n/a n/a 0.0%
30-Jun-11 14.61 92.24 41.37¢ n/a n/a n/a n/a 0.0%
30-Jun-12 27.68 (48.72) (24.90)¢ n/a n/a n/a n/a 0.0%

MSB Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-25 9.70 (63.43) (37.08)¢ n/a n/a n/a n/a 0.0%
30-Jun-26 43.49 (49.73) (31.29)¢ n/a n/a n/a n/a 0.0%
30-Jun-27 241.63 101.50 27.23¢ 4.8 n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Forecast figures based on normalised accounts.

 

MSB Market Data

Currency Australian Dollars
% Change 0.00 %
52 Week High NULL
52 Week Low $0.26
Shares Issued 482.64m

What The Brokers Say

Strong Buy 1
Buy 2
Neutral 1
Sell 0
Strong Sell 0
Total 4
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page